On the other hand, the administration of the proteasome inhibitor, PS-519, interrupts NF-κB activation and preserves myocardial function and thus reduces the MI size in a porcine model of ischemia-reperfusion injury [65]. The gene discussed is NFKB1; the disease is myocardial infarction.